HighTower Advisors
AGN

HighTower Advisors’s Allergan plc AGN Stock Holding History

HighTower Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-900
Closed -$1K – 2476
2018
Q4 		$1K Hold
900
– – ﹤0.01% 2199
2018
Q3 		$1K Hold
900
– – ﹤0.01% 2276
2018
Q2 		$2K Hold
900
– – ﹤0.01% 2207
2018
Q1 		$3K Hold
900
– – ﹤0.01% 2143
2017
Q4 		$4K Buy
+900
New +$162K ﹤0.01% 2219

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

HighTower Advisors's AGN Position: Q2 2020 in Review

HighTower Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 27,431 shares — an estimated $4.86M sold.

HighTower Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $25.3M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • HighTower Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • HighTower Advisors sold 27,431 Allergan plc shares in Q2 2020, an estimated $4.86M.
  • HighTower Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • HighTower Advisors's Allergan plc position peaked at $25.3M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on HighTower Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.